Correlation Between Ultimovacs ASA and Akva

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ultimovacs ASA and Akva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultimovacs ASA and Akva into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultimovacs ASA and Akva Group, you can compare the effects of market volatilities on Ultimovacs ASA and Akva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultimovacs ASA with a short position of Akva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultimovacs ASA and Akva.

Diversification Opportunities for Ultimovacs ASA and Akva

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Ultimovacs and Akva is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Ultimovacs ASA and Akva Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akva Group and Ultimovacs ASA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultimovacs ASA are associated (or correlated) with Akva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akva Group has no effect on the direction of Ultimovacs ASA i.e., Ultimovacs ASA and Akva go up and down completely randomly.

Pair Corralation between Ultimovacs ASA and Akva

Assuming the 90 days trading horizon Ultimovacs ASA is expected to generate 5.32 times more return on investment than Akva. However, Ultimovacs ASA is 5.32 times more volatile than Akva Group. It trades about 0.18 of its potential returns per unit of risk. Akva Group is currently generating about -0.19 per unit of risk. If you would invest  205.00  in Ultimovacs ASA on September 26, 2024 and sell it today you would earn a total of  39.00  from holding Ultimovacs ASA or generate 19.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Ultimovacs ASA  vs.  Akva Group

 Performance 
       Timeline  
Ultimovacs ASA 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ultimovacs ASA are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating essential indicators, Ultimovacs ASA disclosed solid returns over the last few months and may actually be approaching a breakup point.
Akva Group 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Akva Group are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting essential indicators, Akva disclosed solid returns over the last few months and may actually be approaching a breakup point.

Ultimovacs ASA and Akva Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ultimovacs ASA and Akva

The main advantage of trading using opposite Ultimovacs ASA and Akva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultimovacs ASA position performs unexpectedly, Akva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akva will offset losses from the drop in Akva's long position.
The idea behind Ultimovacs ASA and Akva Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets